Terms: = Germ cell tumor AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
771 results:
1. Comparison of insulinoma-associated protein 1 (INSM1) with traditional neuroendocrine markers in gastrointestinal and pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs).
Gao R; Zhang X; Chen X; Lin Y; Jin L; Zheng H; Yu X
Diagn Pathol; 2024 Oct; 19(1):144. PubMed ID: 39472993
[TBL] [Abstract] [Full Text] [Related]
2. Molecular markers for pediatric low-grade glioma.
Levine AB; Hawkins CE
Childs Nerv Syst; 2024 Oct; 40(10):3223-3228. PubMed ID: 39379532
[TBL] [Abstract] [Full Text] [Related]
3. Case Series:
Cortez BN; Kuo MJM; Jha A; Patel M; Carrasquillo JA; Prodanov T; Charles KM; Talvacchio S; Derkyi A; Lin FI; Taïeb D; Del Rivero J; Pacak K
Front Endocrinol (Lausanne); 2024; 15():1399847. PubMed ID: 39351526
[TBL] [Abstract] [Full Text] [Related]
4. Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm.
Mullen B; Sy AL; Dias Goncalves P; Zhang ML
Diagn Pathol; 2024 Sep; 19(1):123. PubMed ID: 39267076
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases].
Xu H; Niu HL; Wang FH; Xu XK; Wang W; Yuan L; Chen K; Gao Q; Li LP; Xia JQ; Guo ZM
Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):922-928. PubMed ID: 39231745
[No Abstract] [Full Text] [Related]
6. Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma.
Zhuang Z; Lin J; Wan Z; Weng J; Yuan Z; Xie Y; Liu Z; Xie P; Mao S; Wang Z; Wang X; Huang M; Luo Y; Yu H
BMC Med; 2024 Sep; 22(1):352. PubMed ID: 39218882
[TBL] [Abstract] [Full Text] [Related]
7. The Clinicopathological Features of the Solitary Subependymal Giant cell Astrocytoma: A Systematic Review.
Piña-Ballantyne SA; Espinosa-Aguilar EJ; Calderón-Garcidueñas AL
Neurol India; 2024 Jul; 72(4):708-717. PubMed ID: 39216021
[TBL] [Abstract] [Full Text] [Related]
8. Comparative genomic landscape of lower-grade glioma and glioblastoma.
Sun X; Jia Q; Li K; Tian C; Yi L; Yan L; Zheng J; Jia X; Gu M
PLoS One; 2024; 19(8):e0309536. PubMed ID: 39208202
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.
Bonada M; Pittarello M; De Fazio E; Gans A; Alimonti P; Slika H; Legnani F; Di Meco F; Tyler B
Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202398
[TBL] [Abstract] [Full Text] [Related]
10. MEN1/DAXX/atrx mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
Gujarathi R; Abou Azar S; Tobias J; Polite BN; Setia N; Feinberg N; Appelbaum DE; Keutgen XM; Liao CY
Endocr Relat Cancer; 2024 Nov; 31(11):. PubMed ID: 39093924
[TBL] [Abstract] [Full Text] [Related]
11. Deep learning-based IDH1 gene mutation prediction using histopathological imaging and clinical data.
Nakagaki R; Debsarkar SS; Kawanaka H; Aronow BJ; Prasath VBS
Comput Biol Med; 2024 Sep; 179():108902. PubMed ID: 39038392
[TBL] [Abstract] [Full Text] [Related]
12. Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.
Jansen P; Galetzka W; Lodde GC; Standl F; Zaremba A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Placke JM; Landsberg J; Möller I; Sucker A; Paschen A; Hadaschik E; Zimmer L; Livingstone E; Schadendorf D; Ugurel S; Stang A; Griewank KG
Eur J Cancer; 2024 Sep; 208():114208. PubMed ID: 39018633
[TBL] [Abstract] [Full Text] [Related]
13. Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
Guidara S; Seyve A; Poncet D; Leonce C; Bringuier PP; McLeer A; Sturm D; Cartalat S; Picart T; Ferrari A; Hench J; Frank S; Meyronet D; Ducray F; Barritault M
J Neurooncol; 2024 Sep; 169(2):391-398. PubMed ID: 38937309
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of Microvascular Density in Glioblastomas in Relation to p53 and Ki67 Immunoexpression.
Sipos TC; Kövecsi A; Kocsis L; Nagy-Bota M; Pap Z
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928515
[TBL] [Abstract] [Full Text] [Related]
15. Loss of atrx and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity.
Yasunaga Y; Tanaka M; Arita J; Hasegawa K; Ushiku T
Hum Pathol; 2024 Aug; 150():51-57. PubMed ID: 38909708
[TBL] [Abstract] [Full Text] [Related]
16. Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation.
Zhu H; Li Y; Ding Y; Liu Y; Shen N; Xie Y; Yan S; Liu D; Zhang X; Li L; Zhu W
J Neurooncol; 2024 Sep; 169(2):287-297. PubMed ID: 38874844
[TBL] [Abstract] [Full Text] [Related]
17. Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.
Andersen KØ; Detlefsen S; Brusgaard K; Christesen HT
Front Endocrinol (Lausanne); 2024; 15():1351624. PubMed ID: 38868744
[TBL] [Abstract] [Full Text] [Related]
18. A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma.
Wilhite AM; Wu S; Xiu J; Gibney GT; Phung T; In GK; Herzog TJ; Khabele D; Erickson BK; Brown J; Rocconi RP; Pierce JY; Scalici JM; Jones NL
Gynecol Oncol; 2024 Sep; 188():13-21. PubMed ID: 38861917
[TBL] [Abstract] [Full Text] [Related]
19. Disease relapse in relation to lymph node sampling in lung carcinoid patients.
Moonen L; Derks JL; Hillen LM; van Suylen RJ; den Bakker MA; Thüsen JHV; Damhuis RA; Buikhuisen WA; van den Broek EC; Maessen J; Maat APWM; van Schil P; Speel EJM; Dingemans AC
Endocr Relat Cancer; 2024 Sep; 31(9):. PubMed ID: 38855984
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Pathology of Gliomas.
Galbraith K; Snuderl M
Clin Lab Med; 2024 Jun; 44(2):149-159. PubMed ID: 38821638
[TBL] [Abstract] [Full Text] [Related]
[Next]